The full Diabetes 2026 scientific program across 3 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.
Day 1
- Oral · In-Person
An intelligent hierarchical medical platform established upon high-quality datasets improves the effectiveness of glycemic management for patients across different levels of hospitals
Zhiheng Zhou · Southern Medical University, China
Currently, the management of blood glucose for inpatients outside the endocrinology department lacks standardization. Common issues include inconsistent diagnosis and treatment of diabetes among hospitals at different…
- Oral · In-Person
Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi · London Northwest Hospital NHS Foundation Trust, United Kingdom
Background: Diabetes technologies, including continuous glucose monitoring (CGM), insulin pumps and hybrid closed loop (HCL) systems, have transformed the management of type 1 diabetes mellitus (T1DM) by improving…
- Workshop
Personalizing progress in type-2 diabetes: Peer-led approaches to holistic care
Marc Cornier · Medical University of South Carolina, United States
Empower endocrinologists to deliver personalized, evidence-based care for patients with type 2 diabetes. Through interactive peer discussions and expert insights, participants will contribute their collective knowledge…
- Workshop
Personalizing progress in type 2 diabetes: Peer-led approaches to holistic care
Melanie Duran · UNM Hospitals, United States
Empower endocrinologists to deliver personalized, evidence-based care for patients with type 2 diabetes. Through interactive peer discussions and expert insights, participants will contribute their collective knowledge…
- Poster · In-Person
Using a multi-disciplinary clinic model to prevent diabetic foot ulcer recurrence
Kaishi Yang · Albert Einstein College of Medicine, United States
Diabetic Foot Ulcer (DFU) is the leading cause of lower extremity amputations in patients living with diabetes. The International Working Group on the Diabetic Foot defines a healed DFU as a DFU in remission since it…
- Poster · In-Person
AI model prediction of dawn phenomenon
Venkat Reddy Dornadula · Pacific Union College, United States
The dawn phenomenon is characterized by a rise in blood glucose levels in the early morning, usually between 4:00 AM and 8:00 AM. It is very common in individuals with diabetes. The rise has been speculated to be due to…
- Poster · In-Person
Impact of Intermittent fasting on glycemic control in adults with Type 2 diabetes: A systematic review of randomized controlled trials
Shaheen Kaplan · Avalon University School of Medicine, United States
Title: Impact of Intermittent Fasting on Glycemic Control in Adults with Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials Background: Intermittent fasting (IF) has emerged as a popular dietary…
- Poster · In-Person
Recurrent diabetic ketoacidosis associated with polysubstance performance-enhancing drug use in previously unrecognised insulin-deficient diabetes
Awais Khan · St. Luke’s Hospital, Ireland
Introduction: Diabetic ketoacidosis (DKA) is a life-threatening metabolic emergency typically associated with type 1 diabetes but may also occur as the first presentation of previously unrecognised diabetes or in…
- Poster · In-Person
Predicting AKI in Vascular surgery patients: A validation study of the Vascular Surgery Kidney Injury Predictive Score
Subrina Anwar · University Hospital Southampton NHS Foundation Trust, United Kingdom
Introduction: Post-operative AKI is not an uncommon complication following vascular surgery and it’s linked to poorer outcomes and longer hospital stay. The VSKIPS tool predicts risk factors for AKI (older age, low…
Day 2
- Oral · In-Person
Diabetes pathogenesis and prevention
Madhu S Malo · Stapgen LLC, United States
Background: Type 2 Diabetes Mellitus (T2DM), characterized by hyperglycemia (≥126 mg glucose/100 ml blood after overnight fasting) and insulin resistance, presents an escalating global health and economic crisis.…
- Oral · In-Person
Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco · Estacio University of Brasília, Brazil
Type 1 Diabetes Mellitus (T1DM) is a chronic autoimmune disease characterized by the destruction of pancreatic beta cells, leading to absolute insulin deficiency. It is most commonly diagnosed in childhood, adolescence…
- Oral · In-Person
Validation of VSKIPS and identification of additional risk factors for post-operative acute kidney injury after vascular surgery
Subrina Anwar · University Hospital Southampton NHS Foundation Trust, United Kingdom
Introduction: Post-operative acute kidney injury (AKI) is a common complication following vascular surgery and is associated with poorer outcomes and longer hospital stay. The VSKIPS tool includes the following…
- Workshop
Beyond daily injections: Implementing once-weekly basal insulin to simplify and personalize care
Marc Cornier · Medical University of South Carolina, United States
Beyond daily injections: Implementing once-weekly basal insulin to simplify and personalize care is designed for US-based endocrinologists and endocrinology-focused NPs and PAs involved in the management of patients…
- Workshop
Beyond daily injections: Implementing once weekly basal insulin to simplify and personalize care
Julio Rosenstock · University of Texas Southwestern Medical Center Dallas, United States
Beyond daily injections: Implementing once-weekly basal insulin to simplify and personalize care is designed for us-based endocrinologists and endocrinology-focused NPs and PAs in the management of patients with Type 2…
Day 3
- Keynote · Virtual
The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak · Universiti Sains Malaysia, Malaysia
The worldwide burden of Non-Communicable Diseases (NCDs) continues to rise, with the prevalence of diabetes anticipated to increase from approximately 180 million cases in 2010 to 368 million by 2030. Diabetes remains a…
- Keynote · Virtual
MTP-ATGL interactions are hydrophobic and change during adipogenesis and fasting to regulate lipolysis in adipocytes
Sujith Rajan · NYU Long Island School of Medicine, United States
Background: Microsomal Triglyceride Transfer Protein (MTP) is a key regulator of lipid metabolism, facilitating lipid transfer and lipoprotein assembly in enterocytes and hepatocytes. We have shown that MTP interacts…
- Oral · Virtual
Differential diagnosis of diabetes in young and prevalence of LADA and LADY in young persons attending tertiary diabetes institute in Bengaluru, India
R Anil Kumar · Karnataka Institute of Endocrinology and Research, India
Dr R.Anil kumar, Professor and HOD Diabetes and endocrinology, Karnataka institute of endocrinology and research, Bangalore-560069. 3370 young diabetes persons were clinically screened 2414 (71.6%) were type 2 diabetes…
- Oral · Virtual
Endocrine-specific diabetes risk modeling, glucose–insulin dynamics, and simulation-based metabolic review using the BVidAL clinical software suite
Abhishek Bansal · New Era Consultancy Services, India
Diabetes mellitus is a complex endocrine and metabolic disorder involving impaired glucose regulation, altered insulin response, pancreatic β-cell dysfunction, adiposity-related metabolic load, vascular stress, renal…
- Oral · Virtual
Shaping the future of diabetes care: New advancements in treatment, digital health and personalized patient care
Rupesh K Gautam · Amity Institute of Pharmacy, India
Diabetes care is rapidly changing as new therapies digital technologies and personalized healthcare approaches continue to improve the way the disease is managed. Due to the increasing global burden of diabetes, there…
- Oral · Virtual
Metabolic health across generations: preventing and controlling diabetes in the modern era
Souravh Bais · Institute of Pharmaceitical Sciences, SAGE University Indore, India
Diabetes mellitus constitutes an escalating global metabolic crisis impacting individuals across all age groups, from early childhood to adulthood. Contemporary diabetes care necessitates a paradigm shift from episodic…
- Oral · Virtual
Enhancing nutrition therapy on diabetics through increased crop productivity
Grace A Asiko · Apiculture Platform of Kenya, Kenya
The dual role honeybees play in increased crop and fruit production through pollination, in addition to Apitherapy, cannot be under-estimated. 80% (percent) of food crops, mainly fruits and vegetables, rely on insect…
- Oral · Virtual
Optimising inpatient hypoglycaemia management: A closed-loop quality improvement project enhancing protocol adherence and patient safety among resident doctors in care of the elderly and acute medicine department at Colchester general hospital
Hyder Khan · Colchester General Hospital, United Kingdom
Background: Inpatient hypoglycaemia is a high-risk medical emergency requiring rapid, standardized management. Adherence to Joint British Diabetes Societies (JBDS) guidelines is critical to prevent severe…
- Oral · Virtual
Intensive versus standard blood pressure control in type 2 diabetes: Cardiovascular and microvascular outcomes
Muhammad Basil Raza · East Lancashire Hospitals NHS Trust, United Kingdom
Introduction : Optimal Blood Pressure (BP) targets in type 2 Diabetes Mellitus (T2DM) remain uncertain. This study aimed to update the evidence on intensive versus standard BP control in T2DM by incorporating recent…
- Poster · Virtual
Improving diabetes self-management education and support referrals in primary care through a standardized referral workflow: A quality improvement initiative
Jordan Gagnon · Creighton University, United States
Background: Diabetes Mellitus affects more than 38 million Americans and is associated with significant morbidity, mortality, and healthcare expenditures. Despite strong evidence supporting Diabetes Self-Management…
Present your research at Diabetes 2027
Abstract submissions for the 2027 program are open · October 25–27, 2027 · Double Tree by Hilton Orlando Downtown, Orlando.
Join the Diabetes 2027 delegation
Orlando · October 25–27, 2027· Hybrid · in-person & virtual
Attend without presenting.
